Innovative Biopharmaceutical Solutions
Developing vaccines and biopharmaceuticals powered by cutting-edge research and advanced technology.
Innovation is at Our Core
At BACTEC PHARMA, we combine scientific research and biotechnology to develop advanced therapeutic solutions
From research to innovation, and from ideas to patents,We move forward with confidence toward building a leading biopharmaceutical future.
Registered Patents
0
+
Veterinary Vaccines in Development
0
+
Human Vaccines in Development
0
+
Strategic Partnerships
0
+
patents
BACTEC PHARMA holds three patents in the field of smart drug delivery systems for the treatment of solid tumors.
Liver Cancer
A bio-carrier system that directs drugs to liver cancer cells to enhance treatment efficacy and reduce side effects.
Lung Cancer
An innovative delivery mechanism targeting lung tumor tissues to improve therapeutic precision and efficiency.
Colon Cancer (Under Development)
An advanced application of the same platform is expanding its potential for the precise treatment of colon tumors.
Our partners
We believe that collaboration is the foundation of innovation; therefore, we build effective scientific and industrial partnerships to accelerate biotechnological development and expand its impact.
News and events
BACTEC PHARMA , we are working to redefine the future of biotherapy through solutions based on advanced scientific research and technologies based on three patents, aiming to develop a new generation of biopharmaceuticals to address global health challenges and enhance the Kingdom’s leadership in the pharmaceutical industry.
Frequently asked questions
1-What is BACTEC PHARMA’s main area of focus?
The company focuses on research and development in the field of biopharmaceuticals and vaccines,
committed to building an advanced national pharmaceutical industry driven by local innovation.
2-Does the company currently have products on the market
BACTEC PHARMA is currently in the research and development (R&D) phase,with plans to launch its first veterinary vaccines by 2027.
3-How does the company contribute to Saudi Vision 2030?
By localizing biopharmaceutical production technologies and enhancing national health and food security through innovative therapeutic solutions.